Accelerate Diagnostics AXDX reported its Q3 earnings results on Thursday, November 9, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Accelerate Diagnostics missed estimated earnings by 10.28%, reporting an EPS of $-1.18 versus an estimate of $-1.07.
Revenue was up $339 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 2.92% increase in the share price the next day.
Here's a look at Accelerate Diagnostics's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -1.40 | -1.4 | -1.5 | -1.9 |
EPS Actual | -1.31 | -1.7 | -1.5 | -1.8 |
Revenue Estimate | 3.60M | 3.35M | 2.87M | 3.75M |
Revenue Actual | 2.92M | 2.81M | 2.97M | 2.96M |
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.